Correlation Between Chugai Pharmaceutical and Scilex Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chugai Pharmaceutical and Scilex Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chugai Pharmaceutical and Scilex Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chugai Pharmaceutical Co and Scilex Holding, you can compare the effects of market volatilities on Chugai Pharmaceutical and Scilex Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chugai Pharmaceutical with a short position of Scilex Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chugai Pharmaceutical and Scilex Holding.

Diversification Opportunities for Chugai Pharmaceutical and Scilex Holding

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Chugai and Scilex is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Chugai Pharmaceutical Co and Scilex Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scilex Holding and Chugai Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chugai Pharmaceutical Co are associated (or correlated) with Scilex Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scilex Holding has no effect on the direction of Chugai Pharmaceutical i.e., Chugai Pharmaceutical and Scilex Holding go up and down completely randomly.

Pair Corralation between Chugai Pharmaceutical and Scilex Holding

Assuming the 90 days horizon Chugai Pharmaceutical Co is expected to generate 0.33 times more return on investment than Scilex Holding. However, Chugai Pharmaceutical Co is 3.04 times less risky than Scilex Holding. It trades about -0.11 of its potential returns per unit of risk. Scilex Holding is currently generating about -0.07 per unit of risk. If you would invest  2,287  in Chugai Pharmaceutical Co on September 16, 2024 and sell it today you would lose (140.00) from holding Chugai Pharmaceutical Co or give up 6.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Chugai Pharmaceutical Co  vs.  Scilex Holding

 Performance 
       Timeline  
Chugai Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chugai Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Scilex Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scilex Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Chugai Pharmaceutical and Scilex Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chugai Pharmaceutical and Scilex Holding

The main advantage of trading using opposite Chugai Pharmaceutical and Scilex Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chugai Pharmaceutical position performs unexpectedly, Scilex Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scilex Holding will offset losses from the drop in Scilex Holding's long position.
The idea behind Chugai Pharmaceutical Co and Scilex Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance